Melanoma can appear startlingly fast, particularly the most aggressive subtype, which grows at roughly four times the rate of the more common forms. Nodular melanoma, the fastest-growing variety, thickens at a median rate of about half a millimeter per month, meaning a dangerous lesion can develop from nothing noticeable to deeply invasive in just a few months. Knowing what to look for goes beyond the familiar “ABCDE” checklist, because a significant fraction of melanomas break the visual rules most people are taught.
Growth Rates Vary Dramatically by Type
Not all melanomas grow at the same pace. Superficial spreading melanoma, the most common subtype, has a median growth rate of about 0.12 mm per month in thickness. Lentigo maligna melanoma, which tends to develop on chronically sun-damaged skin in older adults, grows at a similar pace of roughly 0.13 mm per month. Nodular melanoma is the outlier: it thickens at a median rate of about 0.49 mm per month, roughly four times faster than the other two common types.1JAMA Dermatology. Rate of Growth in Melanomas: Characteristics and Associations of Rapidly Growing Melanomas That speed matters because thickness is the single most important factor in staging and prognosis. A melanoma that reaches 1 mm thick within a couple of months has a meaningfully worse outlook than one caught at half that depth.
In practical terms, a superficial spreading melanoma might take a year or more to become deeply invasive, while a nodular melanoma could reach a dangerous thickness in under three months. This is why some patients recall a spot appearing “out of nowhere” and receiving a serious diagnosis just weeks later. That rapid timeline is not unusual for nodular melanoma. It tends to grow outward less and downward more, which also makes it harder to spot by conventional visual rules.
The Shift from Horizontal to Vertical Growth
Superficial spreading melanomas typically start by expanding horizontally through the upper layer of skin. During this phase, called the radial growth phase, the tumor is generally incapable of spreading to distant organs. One study found that patients whose melanomas were still in this horizontal phase were, on average, about four years younger than those whose tumors had already transitioned to a deeper, vertical growth phase, suggesting the transition takes years in many cases.2Journal of Investigative Dermatology. Lessons from Tumor Progression: The Invasive Radial Growth Phase of Melanoma Is Common, Incapable of Metastasis, and Indolent
Once a melanoma enters the vertical growth phase, it starts pushing downward into deeper tissues, and the risk of metastasis climbs. The growth rate roughly doubles during this shift: superficial spreading melanomas in the vertical phase thicken at about 0.13 mm per month compared to about 0.065 mm per month for those still growing horizontally.3PubMed Central. An observational study regarding the rate of growth in vertical and radial growth phase superficial spreading melanomas
Research using machine-learning analysis of hundreds of melanomas has tried to pin down the physical size at which this dangerous transition typically occurs. For superficial spreading melanomas not arising from a pre-existing mole, the estimated diameter threshold was around 13 mm, though it varied by body site. On the lower limbs, the transition tended to happen at a smaller diameter of about 10 mm, while on the trunk the threshold was closer to 17 mm.4PubMed. Machine learning for the identification of decision boundaries during the transition from radial to vertical growth phase superficial spreading melanomas These are statistical averages, not guarantees. But they reinforce why dermatologists urge you to act on any growing pigmented lesion well before it reaches the size of a dime.
Most Melanomas Do Not Come from Existing Moles
One of the most persistent misconceptions about melanoma is that it always develops from a mole you have had for years. In reality, the majority appear on previously normal-looking skin. A study of 580 melanoma cases found that about 79% were de novo melanomas, meaning they arose on their own, while only about 21% developed from a pre-existing mole.5PubMed Central. Histopathological Differences Between De Novo and Nevus-Associated Melanoma
This matters because many people fixate on monitoring their existing moles while ignoring new spots. Watching your moles is still worthwhile, since roughly one in five melanomas does develop that way. But the bigger priority is paying attention to any new, unfamiliar spot on your skin, especially one that looks different from everything else around it.
The ABCDE Checklist and Where It Falls Short
The ABCDE rule was created 40 years ago to give non-dermatologists and the general public a simple way to evaluate pigmented lesions. It remains the global standard for initial triage of suspicious spots without specialized equipment.6Europe PMC. Advances in the noninvasive diagnosis of melanoma-40 years beyond the ABCDs The criteria are straightforward:
- Asymmetry: one half of the spot does not match the other.
- Border: edges are ragged, blurred, or notched rather than smooth.
- Color: the spot contains multiple shades of brown, black, red, white, or blue rather than one uniform color.
- Diameter: larger than about 6 mm, roughly the size of a pencil eraser.
- Evolution: the spot is changing in size, shape, or color over time.
The “E” criterion is widely considered the most important of the five, because a changing lesion demands attention even if it does not meet the other criteria. A small, symmetric, evenly colored spot that is visibly growing or darkening should still be evaluated.
The limitation of ABCDE is that it was designed around the appearance of classic pigmented melanomas. Nodular melanomas are often symmetric, small, and a uniform dark color, checking very few ABCDE boxes in their early weeks. Amelanotic melanomas, which lack the dark pigment most people associate with skin cancer, can look like a pink bump, a red patch, or even a small wound that will not heal. And melanomas arising on the palms, soles, or under fingernails do not follow the ABCDE pattern at all.
The Ugly Duckling Sign
A useful complement to ABCDE is the “ugly duckling” sign: instead of evaluating a single spot in isolation, you compare it to the surrounding moles. Most of your moles tend to look broadly similar to each other. A melanoma often stands out as the odd one out, the lesion that looks different from its neighbors in color, size, shape, or texture.
Research shows this comparative approach adds real value. In a study where dermatologists reviewed clinical photos from 80 patients, using the ugly duckling approach in combination with lesion-focused analysis reduced the number of spots considered for biopsy by nearly sevenfold compared with examining each lesion individually, while still correctly flagging every melanoma as suspicious.7PubMed. Ugly Duckling Sign as a Major Factor of Efficiency in Melanoma Detection In other words, looking at the bigger pattern helps you spot the real threats without worrying about every slightly irregular mole.
You can apply this at home. Scan a region of your body and get a sense of your “mole signature,” the typical look of your spots. Then look for the outlier. That is the one worth showing a doctor.
Melanomas That Do Not Look Like Melanomas
Amelanotic melanomas are the great mimics. They lack significant pigment and can present as red, pink, or skin-colored bumps. In one study of amelanotic melanomas presenting as red skin lesions, physicians included melanoma in their initial list of possible diagnoses only 32% of the time, compared with 94% for pigmented melanomas. The most common misdiagnosis was basal cell carcinoma, followed by benign conditions like dermatofibroma and eczema.8PubMed Central. Amelanotic Melanomas Presenting as Red Skin Lesions: A Diagnostic Challenge with Potentially Lethal Consequences This diagnostic confusion led to shallower initial biopsies that incompletely removed the lesion in 74% of red amelanotic cases, compared with 41% of pigmented melanomas. Deep margins were positive in 44% of the amelanotic group versus just 9% for pigmented melanomas, meaning the true thickness of the tumor was often underestimated from the start.
Acral lentiginous melanoma is another subtype that defies expectations. It appears on the palms, soles, and under nails, areas that most people never think to check. The standard ABCDE criteria were not designed for nail pigmentation and are largely inapplicable to it.9Journal of the American Academy of Dermatology. The ABC rule for clinical detection of subungual melanoma A dark streak under a fingernail or toenail that is widening, a non-healing sore on the sole of the foot, or a dark spot under a nail with pigment spreading onto the surrounding skin are the warning signs specific to this subtype. Acral lentiginous melanoma is frequently misdiagnosed because of its unusual location and atypical appearance, which contributes to a worse prognosis overall.10PubMed. Metastatic Acral lentiginous melanoma: A case report and review11PubMed Central. Malignant melanoma misdiagnosed as diabetic foot ulcer: A case report
Melanoma in Darker Skin Tones
Melanoma is far less common in people with darker skin, but when it does occur, it tends to be diagnosed later and carries a mortality rate two to three times higher than in lighter-skinned populations. A major reason is that about 70% of melanomas in people with darker skin arise on the plantar surface of the foot, a location that practitioners often overlook and where many clinicians lack confidence in distinguishing benign from malignant lesions.12PubMed Central. Melanoma: Does It Present Differently in Darker Skin Tones?
This creates a dangerous gap. Public health messaging about melanoma overwhelmingly emphasizes checking sun-exposed skin for dark, irregularly pigmented spots. For people with darker skin, that messaging misses the most common site entirely. If you have dark skin, checking the soles of your feet, between your toes, under your nails, and on your palms is more relevant than scanning your back and shoulders. A dark streak under a nail, a non-healing wound on the sole, or a spot with uneven pigment in these areas deserves prompt evaluation.
How Sunburn Connects to Future Melanoma Risk
UV exposure is the most modifiable risk factor for melanoma, and the connection with sunburn is well established across all age groups. A comprehensive meta-analysis found that an increasing number of sunburns at any life stage, whether in childhood, adolescence, or adulthood, was associated with higher melanoma risk.13PubMed Central. Sunburns and risk of cutaneous melanoma, does age matter: a comprehensive meta-analysis
There has been debate about whether childhood sunburns carry uniquely outsized risk. Some data suggest they do: a Mendelian randomization study, which uses genetic variation to estimate causal effects, found that genetically predicted childhood sunburn was associated with roughly a fourfold increased risk of melanoma.14PubMed Central. Childhood sunburn and risk of melanoma and non-melanoma skin cancer: a Mendelian randomization study But other research has found that adult sunburns also carry strong independent risk. One study reported a relative risk of about 2.2 for people with a history of more than five sunburns after age 19, and did not find a uniquely elevated risk from childhood burns in their own data.15European Journal of Cancer. At what age do sunburn episodes play a crucial role for the development of malignant melanoma
The practical takeaway is that sunburns at any age matter, and you should not assume that childhood sun damage is the only thing that counts. Every blistering burn contributes to cumulative risk. Adults who got through childhood without significant burns sometimes let their guard down, assuming the critical window has passed. It has not.
Immunosuppressed Individuals and Transplant Recipients
People on immunosuppressive medications face a markedly higher risk of developing melanoma and dying from it. Solid organ transplant recipients have roughly a ninefold increased risk of developing a new invasive melanoma compared to the general population. More strikingly, melanoma mortality in this group is about 52 times higher than expected.16PubMed Central. Outcomes in solid organ transplant recipients with a pretransplant diagnosis of melanoma The immune system plays a critical role in keeping early melanoma cells in check, and when that surveillance is suppressed, tumors can emerge faster and progress more aggressively.
If you are a transplant recipient or take immunosuppressive medications for any reason, regular full-body skin exams with a dermatologist are especially important. Spots that might remain indolent for years in someone with a healthy immune system can behave much more dangerously in your situation.
Self-Examination and When to Get Help
Regular skin self-examination makes a measurable difference. A randomized controlled trial of women at elevated melanoma risk found that those trained in structured self-examination identified atypical moles at more than four times the rate of the control group, and detected melanomas at more than five times the rate.17Preventive Medicine Reports. Melanoma detection by skin self-examination targeting at-risk women: A randomized controlled trial with telemedicine support for concerning moles The point is not that you need to be an expert. It is that systematically looking at your skin, getting familiar with your baseline, and flagging changes gives you a genuine head start on catching melanoma early.
A practical self-check routine does not require special equipment. Pick a consistent day each month. Use a full-length mirror and a hand mirror for areas you cannot see directly. Check your scalp, between your toes, the soles of your feet, and under your nails. Photograph any spot that catches your attention so you can compare it over time. If something is new, changing, or stands out from the pattern around it, schedule a dermatology appointment rather than waiting to see what happens.
AI-Assisted Detection Tools
Smartphone apps and dermatology software increasingly use artificial intelligence to evaluate skin lesions. Some of these tools report impressive performance in controlled settings, with models achieving around 92% accuracy in distinguishing benign from malignant skin lesions in dermoscopic images.18Cureus. Artificial Intelligence in Dermoscopy: Enhancing Diagnosis to Distinguish Benign and Malignant Skin Lesions
Those numbers sound reassuring, but there are real caveats. Most AI models are trained predominantly on images of pigmented lesions from lighter skin, which means their accuracy drops for amelanotic melanomas and for lesions on darker skin. An app that tells you a spot “looks benign” is not a substitute for clinical judgment, especially for the subtypes that already evade visual detection rules. These tools work best as a complement to, not a replacement for, periodic dermatologist exams. If a tool flags something suspicious, follow up. But if it tells you a changing or unusual spot is fine and your gut says otherwise, trust your gut and see a professional anyway.